CTRI/2022/06/043262
Not yet recruiting
未知
An Observational Study on Prevalence of Diseases w.s.r.to Deha Prakriti and Zodiac Sign (Janma Rashi)of Patient.
Dr Deepti Parashar0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Deepti Parashar
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients willing to provide necessary data.
- •patients who exactly know their date, place \& time of birth.
- •patients of chronic and already diagnosed disorders.
- •patients who understand the need of survey and give written consent.
Exclusion Criteria
- •1\.Patients not willing to provide necessary data.
- •2\.Patients who do not exactly know their date, place \& time of birth.
- •3\.Patients of acute and undiagnosed disorders.
- •4\.Patients who do not understand the need of survey and do not give written consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study On The Profile And Vision Related Quality Of Life In Ocular And Orbital Injuries Due To Blunt Trauma In A Tertiary Care CentreCTRI/2019/11/021846Dr Megha Nair
Recruiting
Not Applicable
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR)Mutation Status in Non-Small Cell Lung Cancer (NSCLC) in India.Health Condition 1: null- Non Small Cell Lung CancerCTRI/2013/10/004077Roche Products India Pvt Ltd250
Not yet recruiting
Not Applicable
A Study at Sawai Man Singh Medical College and Attached Hospitals, Jaipur to Find Out the Number of Patients Having Reduced Heart Rate in Lying Down Position, Reduced Blood Pressure in Lying Down Position and Fall in Blood Pressure in Sitting Position Among Patients of Spine InjuryCTRI/2024/04/066465SMS Medical College Jaipur
Completed
Not Applicable
Epidemiological Study to Evaluate the Prevalence and Progression of Diabetic Macular Ischemia in Patients with Diabetic Retinopathy Treated with Panretinal PhotocoagulatioJPRN-UMIN000042801Boehringer Ingelheim International GmbH539
Recruiting
Not Applicable
Epidemiological Study to Determine the Prevalence of ctDNA Positivity in Participants With Stage II (High Risk) or Stage III CRC After Surgery With Curative (R0) Intent and Subsequent Adjuvant Chemotherapy With Monitoring of ctDNA During Clinical Follow-upColorectal Cancer Stage IIColorectal Cancer Stage IIIDRKS00025104BioNTech SE1,500